Search
International Breast Cancer Conference Features UCSF Health Experts
Breast cancer experts from UCSF Health will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference. This year’s meeting will be held Dec. 7-10.Clinical Advance - Minimally Invasive Cardiac Surgery
UCSF Health is a major referral and destination center for minimally invasive cardiac surgery, featuring high volumes, extensive experience and quality outcomes.UCSF’s Julie Ann Sosa, MD, Named President-Elect of the American Thyroid Association
Julie Ann Sosa, MD, MA, FACS, endocrine surgeon and chair of the Department of Surgery at UC San Francisco, has been named president-elect of the American Thyroid Association (ATA). She was previously the ATA’s treasurer.New Evidence on How Alcohol and Caffeine Affect Heart Rhythm Found in UCSF Studies
In separate studies, UC San Francisco researchers examined the effects of two widely consumed beverages – coffee and alcohol – on irregular heartbeat.Javid Moslehi, MD, Named Chief of the New UCSF Cardio-Oncology & Immunology Program
Javid Moslehi, MD, has been named section chief of the new Cardio-Oncology & Immunology Program at UC San Francisco, which brings together cardiologists, oncologists, immunologists and researchers to promote the cardiovascular health of patients during cancer treatment and survivorship.Manipulating Gut Microbiomes to Treat inflammatory Bowel Disease
Researchers at the Benioff Center for Microbiome Medicine at UCSF are working to accelerate understanding of how microbes promote health and prevent disease and to leverage this information to develop novel, effective treatments in the shortest possible time.Living Kidney Donation
The UCSF Connie Frank Transplant Center continues to explore new options, such as advanced donation vouchers, to provide patients who have end-stage renal disease (ESRD) the opportunity for a living donor transplant.UCSF-Led Study Confirms Some Cancer Immunotherapies May Lead to Myocarditis and Other Potentially Serious Arrhythmias
Immune checkpoint inhibitors (ICIs) have transformed cancer care by unleashing T-cells to fight tumors, but they can cause serious cardiotoxicities including myocarditis.Newly Approved Prostate Cancer Scan Can Detect Cells that Have Spread to Lymph Nodes
A revolutionary new diagnostic method for prostate cancer can detect prostate cancer cells that have spread to lymph nodes both inside and outside the pelvis, according to the UC San Francisco and UCLA team whose earlier work led to the test’s FDA approval.Cognitive Ability Improved in Low-Grade Glioma Patients Treated at UCSF
With advanced treatments improving survival outcomes for patients with low-grade gliomas, clinicians and researchers at UC San Francisco’s Brain Tumor Center are working to enhance the cognitive improvement of these individuals as well.UCSF Post-COVID Clinic Treats Long Haulers
UC San Francisco’s OPTIMAL Clinic (pOst-covid-19/PosT-Icu MultidisciplinAry cLinic) is one of the first clinics in the country established to provide follow-up care for patients who have recovered from COVID-19. The clinic’s goal is to optimize patient recovery through a centralized resource designed to coordinate with primary care services.UCSF’s Lawrence Fong, MD, Earns NCI Award for Cancer Immunotherapy Research
The National Cancer Institute (NCI)has honored Lawrence H. Fong, MD, leader of the UC San Francisco Cancer Immunotherapy Program, with an Outstanding Investigator Award (R35).These awards support investigators who have significant records of productivity in cancer research with multiyear funding for projects of exceptional potential.State-of-the-Art Weill Neurosciences Building Opens at UCSF
The Joan and Sanford I. Weill Neurosciences Building opened its doors in July 2021, establishing an innovative all-in-one hub for patients, researchers and clinicians at UC San Francisco’s Mission Bay campus.Hemodialysis Significantly Decreased for Patient with Primary Hyperoxaluria Type 1 in UCSF Study of Nedosiran
Researchers at UC San Francisco reported successful compassionate use of nedosiran to dramatically reduce plasma oxalate levels in a patient with primary hyperoxaluria type 1 (PH1).An Extraordinary Response: A Young Woman’s Path to Overcoming Metastatic Colon Cancer
28-year-old woman mother of two was healthy up until a month prior, when she developed severe anemia, diarrhea and emesis, accompanied by a 25-pound weight loss.Ranked No. 5 in the U.S. for ENT, UCSF to Host Conference on Latest Research and Treatments in Otolaryngology – Head and Neck Surgery
The UC San Francisco Department of Otolaryngology – Head and Neck Surgery is sponsoring the UCSF Otolaryngology Update 2021, taking place November 11 to 13, 2021.John de Groot, MD, Named Division Chief of Neuro-Oncology at UCSF
John F. de Groot, MD, has been named the new chief of the Division of Neuro-Oncology within the Department of Neurological Surgery at UC San Francisco.New Practice Guidance on Malnutrition, Frailty and Sarcopenia in Patients With Cirrhosis, Led by UCSF Researcher
The first-ever American Association for the Study of Liver Diseases (AASLD) Practice Guidance on the management of malnutrition, frailty and sarcopenia in patients with cirrhosis is now available.COVID-19 During Pregnancy Associated with Preterm Birth, UCSF-Led Study Finds
Pregnant people infected with COVID-19 face an increased risk of very preterm birth (VPTB), preterm birth (PTB) or early term birth, according to a large population-based study led by researchers at UC San Francisco.New Guidance on Using Biologics to Treat Chronic Rhinosinusitis with Nasal Polyps, Led by UCSF Clinician
Approximately 25 percent of people with chronic rhinosinusitis have nasal polyps, a condition associated with significant morbidity and decreased quality of life.Lung Transplant Outcomes at UCSF Among the Nation’s Best
For nine consecutive years, the UCSan FranciscoLung Transplant Program has achieved significantly higher-than-expected survival rates following transplant surgery. It is the only lung transplant program in the country with this record.Epilepsy Center
The UCSF Epilepsy Center is the Bay Area’s premier level 4 epilepsy center, the highest possible rating from the National Association of Epilepsy Centers.Olfactory Loss from COVID-19 Infection: Cause and Treatments Studied at UCSF
Complete (anosmia) and incomplete (hyposmia) smell sensitivity impairment are widely reported indicators among the many symptoms of COVID-19 infection. Quality of life can be substantially impacted by the loss of taste and smell, with possible effects including depression, loss of appetite, and safety risks from lack of awareness of gas leaks, smoke or spoiled food. The path to recovery of taste and smell varies widely among affected individuals.UCSF500 Cancer Gene Panel Test
The UCSF500 Cancer Gene Panel leverages world-class expertise for advanced cancer cases. Designed by our leading cancer specialists, the UCSF500 offers unparalleled depth and precision in genetic analysis.